Modified dose of guselkumab for treatment of pyoderma gangrenosum

Ashley M Reese; Katherine Erickson; Katherine B Reed; Alex G Ortega-Loayza

doi:10.1016/j.jdcr.2021.11.030

Modified dose of guselkumab for treatment of pyoderma gangrenosum

JAAD Case Rep. 2022 Jan 6:21:38-42. doi: 10.1016/j.jdcr.2021.11.030. eCollection 2022 Mar.

Authors

Ashley M Reese¹, Katherine Erickson², Katherine B Reed³, Alex G Ortega-Loayza⁴

Affiliations

¹ School of Medicine, Oregon Health & Science University, Portland, Oregon.
² Department of Internal Medicine, Providence Portland Medical Center, Portland, Oregon.
³ Dermatology Specialists of Spokane, Spokane, State of Washington.
⁴ Department of Dermatology, Oregon Health & Science University, Portland, Oregon.

No abstract available

Keywords: DVT, deep venous thrombosis; IL, interleukin; LLE, left lower extremity; PG, pyoderma gangrenosum; biologics (Rx); clinical cases; immunobiologics; leg ulcers; medical dermatology; pyoderma gangrenosum; ulcers; wounds & wound healing.

Publication types

Case Reports